
NuCana is a biotechnology business based in the US. NuCana shares (NCNA) are listed on the NASDAQ and all prices are listed in US Dollars. NuCana employs 31 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy NuCana stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – NCNA. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Easy to use platform with low fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
NuCana stock price (NASDAQ: NCNA)
Use our graph to track the performance of NCNA stocks over time.NuCana shares at a glance
Latest market close | $1.55 |
---|---|
52-week range | $0.52 - $3.32 |
50-day moving average | $1.03 |
200-day moving average | $1.07 |
Wall St. target price | $3.73 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.92 |
Buy NuCana stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy NuCana stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
NuCana price performance over time
Historical closes compared with the close of $1.55 from 2023-02-02
1 week (2023-01-27) | 9.93% |
---|---|
1 month (2023-01-04) | 85.23% |
3 months (2022-11-04) | 46.23% |
6 months (2022-08-04) | -14.36% |
1 year (2022-02-03) | -44.84% |
---|---|
2 years (2021-02-04) | -75.82% |
3 years (2020-02-04) | 5.32 |
5 years (2018-02-02) | 23.13 |
NuCana financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -32.9% |
Return on equity TTM | -46.82% |
Profit margin | 0% |
Book value | $1.02 |
Market capitalisation | $82.5 million |
TTM: trailing 12 months
NuCana share dividends
We're not expecting NuCana to pay a dividend over the next 12 months.
NuCana share price volatility
Over the last 12 months, NuCana's shares have ranged in value from as little as $0.517 up to $3.32. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NuCana's is 0.9379. This would suggest that NuCana's shares are less volatile than average (for this exchange).
NuCana overview
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients with recurrent ovarian cancer; Phase Ib clinical trials for the treatment of patients with biliary tract cancer; Phase II clinical trial for the treatment of patients with platinum-resistant ovarian cancer; and Phase III clinical trial for the treatment of patients with pancreatic cancer. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil, which is in Phase I clinical trial for the treatment of patients with advanced solid tumors and in a Phase 1b/2 clinical trial for patients with advanced colorectal cancer; and NUC-7738, a nucleoside analog that is in Phase 1/2 clinical trial for the treatment of patients with advanced solid tumors and hematological tumors. It has a research, collaboration, and license agreement with Cardiff University and University College Cardiff Consultants Ltd. for the design, synthesis, characterization, and evaluation of ProTides; and an assignment, license, and collaboration agreement with Cardiff ProTides Ltd. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017.
NuCana in the news
NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement

NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
NuCana Announces Receipt of NASDAQ Notice
Frequently asked questions
What percentage of NuCana is owned by insiders or institutions?Currently 0.351% of NuCana shares are held by insiders and 32.077% by institutions. How many people work for NuCana?
Latest data suggests 31 work at NuCana. When does the fiscal year end for NuCana?
NuCana's fiscal year ends in December. Where is NuCana based?
NuCana's address is: 3 Lochside Way, Edinburgh, United Kingdom, EH12 9DT What is NuCana's ISIN number?
NuCana's international securities identification number is: US67022C1062 What is NuCana's CUSIP number?
NuCana's Committee on Uniform Securities Identification Procedures number is: 67022C106
More guides on Finder
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert